A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)
Clinical trial NCT00406419 · TERMINATED
Trial details
- NCT number
- NCT00406419
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-27
- Primary completion
- 2009-10-06
- Enrollment
- 1015
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.